These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 20442421)

  • 1. Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.
    Zimmerman B; Niewiesk S; Lairmore MD
    Vet Pathol; 2010 Jul; 47(4):677-89. PubMed ID: 20442421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of innate immune responses during human T-cell leukemia virus (HTLV-1) pathogenesis.
    Olière S; Douville R; Sze A; Belgnaoui SM; Hiscott J
    Cytokine Growth Factor Rev; 2011 Aug; 22(4):197-210. PubMed ID: 21924945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fucoidan therapy decreases the proviral load in patients with human T-lymphotropic virus type-1-associated neurological disease.
    Araya N; Takahashi K; Sato T; Nakamura T; Sawa C; Hasegawa D; Ando H; Aratani S; Yagishita N; Fujii R; Oka H; Nishioka K; Nakajima T; Mori N; Yamano Y
    Antivir Ther; 2011; 16(1):89-98. PubMed ID: 21311112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T cell leukemia virus type I-induced disease: pathways to cancer and neurodegeneration.
    Barmak K; Harhaj E; Grant C; Alefantis T; Wigdahl B
    Virology; 2003 Mar; 308(1):1-12. PubMed ID: 12706085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms.
    Yasunaga J; Matsuoka M
    Cancer Control; 2007 Apr; 14(2):133-40. PubMed ID: 17387298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state.
    Yasunaga Ji ; Sakai T; Nosaka K; Etoh Ki ; Tamiya S; Koga S; Mita S; Uchino M; Mitsuya H; Matsuoka M
    Blood; 2001 May; 97(10):3177-83. PubMed ID: 11342446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a Cynomolgus Macaque Model of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Direct Inoculation of Adult T-Cell Leukemia Patient-Derived Cell Lines for HTLV-1 Infection.
    Urano E; Ueda K; Higuchi M; Furukawa M; Okamura T; Tanaka Y; Yasutomi Y
    J Virol; 2022 Nov; 96(22):e0133922. PubMed ID: 36314828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animals Models of Human T Cell Leukemia Virus Type I Leukemogenesis.
    Niewiesk S
    ILAR J; 2016; 57(1):3-11. PubMed ID: 27034390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An animal model of adult T-cell leukemia: humanized mice with HTLV-1-specific immunity.
    Tezuka K; Xun R; Tei M; Ueno T; Tanaka M; Takenouchi N; Fujisawa J
    Blood; 2014 Jan; 123(3):346-55. PubMed ID: 24196073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon.
    Kinpara S; Hasegawa A; Utsunomiya A; Nishitsuji H; Furukawa H; Masuda T; Kannagi M
    J Virol; 2009 May; 83(10):5101-8. PubMed ID: 19264779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein].
    Kozako T
    Yakugaku Zasshi; 2011; 131(7):1061-72. PubMed ID: 21720136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depletion of dendritic cells enhances susceptibility to cell-free infection of human T cell leukemia virus type 1 in CD11c-diphtheria toxin receptor transgenic mice.
    Rahman S; Manuel SL; Khan ZK; Wigdahl B; Acheampong E; Tangy F; Jain P
    J Immunol; 2010 May; 184(10):5553-61. PubMed ID: 20382884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network.
    Goncalves DU; Proietti FA; Barbosa-Stancioli EF; Martins ML; Ribas JG; Martins-Filho OA; Teixeira-Carvalho A; Peruhype-Magalhães V; Carneiro-Proietti AB
    Inflamm Allergy Drug Targets; 2008 Jun; 7(2):98-107. PubMed ID: 18691139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of TSLC1 in patients with HAM/TSP.
    Takenouchi N; Tanaka M; Sato T; Yao J; Fujisawa JI; Izumo S; Kubota R; Matsuura E
    J Neurovirol; 2020 Jun; 26(3):404-414. PubMed ID: 32285300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.